Intercellular adhesion molecule-1 in patients with idiopathic interstitial pneumonia

Area of Science:

• Pulmonary Medicine
• Immunology
• Cell Biology

Background:

• Interstitial pulmonary diseases encompass conditions like usual interstitial pneumonia (UIP), bronchiolitis obliterans organizing pneumonia (BOOP), and nonspecific interstitial pneumonia (NSIP).
• Intercellular adhesion molecule-1 (ICAM-1) is implicated in inflammatory and immune responses, but its specific role in fibrotic lung diseases requires elucidation.

Purpose of the Study:

• To investigate the role of intercellular adhesion molecule-1 (ICAM-1) in interstitial pulmonary diseases.
• To assess soluble ICAM-1 levels in serum and bronchoalveolar lavage fluid (BALF) and its expression in lung tissue.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) was used to quantify soluble ICAM-1 in serum and BALF from patients with UIP, BOOP, NSIP, and healthy controls.
• Immunohistochemical staining was performed on lung tissue samples to evaluate ICAM-1 expression.

Main Results:

• Serum soluble ICAM-1 levels were significantly higher in patients with UIP and NSIP compared to healthy subjects; elevated levels were also observed in BOOP patients.
• Soluble ICAM-1 levels in BALF were generally higher in all patient groups compared to controls, with a significant correlation between serum and BALF levels.
• ICAM-1 expression was markedly increased in lung tissues of UIP patients, particularly in type II alveolar epithelium and vascular endothelium, correlating positively with BALF soluble ICAM-1 levels.

Conclusions:

• Increased ICAM-1 expression in lung tissue, especially in type II alveolar epithelium, suggests a specific role in the fibrotic processes of interstitial pneumonia.
• Measurement of soluble ICAM-1 in serum and BALF may serve as a valuable biomarker for assessing the progression of lung fibrosis.